Scientists at the Izmir Biomedicine and Genome Center (IBG) have developed a novel therapeutic agent aimed at treating the condition commonly known as macular degeneration, which originates from visual impairment in the retina.
- Anadolu Ajansı
- HABERTÜRK
- SON DAKİKA
- Yeni Şafak
- YENİGÜN
Newspapers:


